ÑÇÖÞAV

With the opening of the Nanofabrication Facility on its Science and Technology Campus, Mason stands ready to conduct state-of-the-art research and to help train the next generation of innovators.

Probiotic supplementation staved off the negative effects associated with a high-fat diet, illustrating how probiotics may play a key role in preventative health care, Mason study indicates.

In partnership with Phoenix Advantage, a Virginia-based economic development and business consulting firm, Caroline Sutter of Mason’s College of Public Health; Amy Adams, executive director of the Institute for Biohealth Innovation; and their team have received a life science talent pathway planning grant from GO Virginia, a state-funded initiative administered by the Virginia Department of Housing and Community Development.

Mason infectious disease researcher Aarthi Narayanan has partnered with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and Cyclica, a biotechnology company based in Canada, to identify potential broad-spectrum therapeutics for illnesses triggered by HFVs and similar pathogens.

The NSF Research Traineeship Program program was established in 2019 with a five-year grant of nearly $3 million from the National Science Foundation and is preparing an interdisciplinary, community-engaged STEM workforce with the expertise necessary for cross-disciplinary collaboration.

ÑÇÖÞAV has received a $3.75M per capita grant from GO Virginia, a state-funded initiative administered by the Virginia Department of Housing and Community Development.

Jack is a member of the Gender Exploration of Neurogenetics and Development to Advanced Autism Research Consortium, a National Institutes of Health-funded Autism Centers of Excellence (ACE) network focused on learning more about how sex and gender relate to biology, behavior, and the well-being of autistic children, teenagers, and young adults.

Virongy, which was started by Mason researcher Yuntao Wu in 2013, is one of the life science companies that is part of the Northern Virginia BioHub, which was recently established through Virgina Bio-Connect

With COVID-19 continuing to spread throughout the world, there is a demand for rapid, noninvasive diagnostics. ÑÇÖÞAV researchers Robin Couch and Allyson Dailey, members of the College of Science and the Institute of Biohealth Innovation, are working to answer that call with their research on volatile organic compounds (VOCs) for infectious disease detection.

The localized enlargement of arteries in the brain, known as cerebral aneurysms, can have devastating consequences. Mason researcher Juan Cebral and his team are studying major risk factors for aneurysms and how to identify high-risk patients who need prompt and aggressive treatments.